Skip to main content
Erschienen in: European Journal of Nutrition 1/2013

01.02.2013 | Original Contribution

Effect of hereditary haemochromatosis genotypes and iron overload on other trace elements

verfasst von: Jeffrey M. Beckett, Madeleine J. Ball

Erschienen in: European Journal of Nutrition | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hereditary haemochromatosis is a common genetic disorder involving dysregulation of iron absorption. There is some evidence to suggest that abnormal iron absorption and metabolism may influence the status of other important trace elements. In this study, the effect of abnormal HFE genotypes and associated iron overload on the status of other trace elements was examined.

Methods

Dietary data and blood samples were collected from 199 subjects (mean age = 55.4 years; range = 21–81 years). Dietary intakes, serum selenium, copper and zinc concentrations and related antioxidant enzymes (glutathione peroxidase and superoxide dismutase) in subjects with normal HFE genotype (n = 118) were compared to those with abnormal HFE genotype, with both normal iron status (n = 42) and iron overload (n = 39).

Results

For most dietary and biochemical variables measured, there were no significant differences between study groups. Red cell GPx was significantly higher in male subjects with normal genotypes and normal iron status compared to those with abnormal genotypes and normal iron status (P = 0.03) or iron overload (P = 0.001). Red cell GPx was also highest in normal women and significantly lower in the abnormal genotype and normal iron group (P = 0.016), but not in the iron overload group (P = 0.078).

Conclusion

Although it may not be possible to exclude a small effect between the genotype groups on RBC GPx, overall, haemochromatosis genotypes or iron overload did not appear to have a significant effect on selenium, copper or zinc status.
Literatur
1.
Zurück zum Zitat Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278CrossRef Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278CrossRef
2.
Zurück zum Zitat Pietrangelo A (2003) Haemochromatosis. Gut 52(Suppl 2):23–30 Pietrangelo A (2003) Haemochromatosis. Gut 52(Suppl 2):23–30
3.
Zurück zum Zitat Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619–623 Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A (2001) Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 108:619–623
4.
Zurück zum Zitat Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77–82CrossRef Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36:77–82CrossRef
5.
Zurück zum Zitat Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25:14–15CrossRef Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 25:14–15CrossRef
6.
Zurück zum Zitat Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 114:474–484CrossRef Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M (2001) HFE mutations, iron deficiency and overload in 10,500 blood donors. Br J Haematol 114:474–484CrossRef
7.
Zurück zum Zitat Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G → A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211–218CrossRef Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845G → A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359:211–218CrossRef
8.
Zurück zum Zitat Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG (2004) Hemochromatosis mutations in the general population: iron overload progression rate. Blood 103:2914–2919CrossRef Andersen RV, Tybjaerg-Hansen A, Appleyard M, Birgens H, Nordestgaard BG (2004) Hemochromatosis mutations in the general population: iron overload progression rate. Blood 103:2914–2919CrossRef
9.
Zurück zum Zitat Cadet E, Capron D, Gallet M, Omanga-Leke ML, Boutignon H, Julier C, Robson KJ, Rochette J (2005) Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases? J Med Genet 42:390–395CrossRef Cadet E, Capron D, Gallet M, Omanga-Leke ML, Boutignon H, Julier C, Robson KJ, Rochette J (2005) Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases? J Med Genet 42:390–395CrossRef
10.
Zurück zum Zitat Trinder D, Fox C, Vautier G, Olynyk JK (2002) Molecular pathogenesis of iron overload. Gut 51:290–295CrossRef Trinder D, Fox C, Vautier G, Olynyk JK (2002) Molecular pathogenesis of iron overload. Gut 51:290–295CrossRef
11.
Zurück zum Zitat Franchini M, Veneri D (2005) Hereditary hemochromatosis. Haematology 10:145–149CrossRef Franchini M, Veneri D (2005) Hereditary hemochromatosis. Haematology 10:145–149CrossRef
12.
Zurück zum Zitat Wood MJ, Powell LW, Ramm GA (2008) Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood 111:4456–4462CrossRef Wood MJ, Powell LW, Ramm GA (2008) Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. Blood 111:4456–4462CrossRef
13.
Zurück zum Zitat Chua AC, Graham RM, Trinder D, Olynyk JK (2007) The regulation of cellular iron metabolism. Crit Rev Clin Lab Sci 44:413–459CrossRef Chua AC, Graham RM, Trinder D, Olynyk JK (2007) The regulation of cellular iron metabolism. Crit Rev Clin Lab Sci 44:413–459CrossRef
14.
Zurück zum Zitat Moghadaszadeh B, Beggs AH (2006) Selenoproteins and their impact on human health through diverse physiological pathways. Physiology 21:307–315CrossRef Moghadaszadeh B, Beggs AH (2006) Selenoproteins and their impact on human health through diverse physiological pathways. Physiology 21:307–315CrossRef
15.
Zurück zum Zitat Klotz LO, Kroncke KD, Buchczyk DP, Sies H (2003) Role of copper, zinc, selenium and tellurium in the cellular defence against oxidative and nitrosative stress. J Nutr 133:1448S–1451S Klotz LO, Kroncke KD, Buchczyk DP, Sies H (2003) Role of copper, zinc, selenium and tellurium in the cellular defence against oxidative and nitrosative stress. J Nutr 133:1448S–1451S
16.
Zurück zum Zitat Garrick MD, Singleton ST, Vargas F, Kuo HC, Zhao L, Knopfel M, Davidson T, Costa M, Paradkar P, Roth JA, Garrick LM (2006) DMT1: which metals does it transport? Biol Res 39:79–85CrossRef Garrick MD, Singleton ST, Vargas F, Kuo HC, Zhao L, Knopfel M, Davidson T, Costa M, Paradkar P, Roth JA, Garrick LM (2006) DMT1: which metals does it transport? Biol Res 39:79–85CrossRef
17.
Zurück zum Zitat Tallkvist J, Bowlus CL, Lonnerdal B (2003) Effect of iron treatment on nickel absorption and gene expression of the divalent metal transporter (DMT1) by human intestinal Caco-2 cells. Pharmacol Toxicol 92:121–124CrossRef Tallkvist J, Bowlus CL, Lonnerdal B (2003) Effect of iron treatment on nickel absorption and gene expression of the divalent metal transporter (DMT1) by human intestinal Caco-2 cells. Pharmacol Toxicol 92:121–124CrossRef
18.
Zurück zum Zitat Bressler JP, Olivi L, Cheong JH, Kim Y, Bannona D (2004) Divalent metal transporter 1 in lead and cadmium transport. Ann NY Acad Sci 1012:142–152CrossRef Bressler JP, Olivi L, Cheong JH, Kim Y, Bannona D (2004) Divalent metal transporter 1 in lead and cadmium transport. Ann NY Acad Sci 1012:142–152CrossRef
19.
Zurück zum Zitat Bannon DI, Portnoy ME, Olivi L, Lees PS, Culotta VC, Bressler JP (2002) Uptake of lead and iron by divalent metal transporter 1 in yeast and mammalian cells. Biochem Biophys Res Commun 295:978–984CrossRef Bannon DI, Portnoy ME, Olivi L, Lees PS, Culotta VC, Bressler JP (2002) Uptake of lead and iron by divalent metal transporter 1 in yeast and mammalian cells. Biochem Biophys Res Commun 295:978–984CrossRef
20.
Zurück zum Zitat Park JD, Cherrington NJ, Klaassen CD (2002) Intestinal absorption of cadmium is associated with divalent metal transporter 1 in rats. Toxicol Sci 68:288–294CrossRef Park JD, Cherrington NJ, Klaassen CD (2002) Intestinal absorption of cadmium is associated with divalent metal transporter 1 in rats. Toxicol Sci 68:288–294CrossRef
21.
Zurück zum Zitat Peres JM, Bureau F, Neuville D, Arhan P, Bougle D (2001) Inhibition of zinc absorption by iron depends on their ratio. J Trace Elem Med Biol 15:237–241CrossRef Peres JM, Bureau F, Neuville D, Arhan P, Bougle D (2001) Inhibition of zinc absorption by iron depends on their ratio. J Trace Elem Med Biol 15:237–241CrossRef
22.
Zurück zum Zitat Wapnir RA (1998) Copper absorption and bioavailability. Am J Clin Nutr 67:1054S–1060S Wapnir RA (1998) Copper absorption and bioavailability. Am J Clin Nutr 67:1054S–1060S
23.
Zurück zum Zitat Zoller H, Koch RO, Theurl I, Obrist P, Pietrangelo A, Montosi G, Haile DJ, Vogel W, Weiss G (2001) Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 120:1412–1419CrossRef Zoller H, Koch RO, Theurl I, Obrist P, Pietrangelo A, Montosi G, Haile DJ, Vogel W, Weiss G (2001) Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 120:1412–1419CrossRef
24.
Zurück zum Zitat Zoller H, Pietrangelo A, Vogel W, Weiss G (1999) Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 353:2120–2123CrossRef Zoller H, Pietrangelo A, Vogel W, Weiss G (1999) Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 353:2120–2123CrossRef
25.
Zurück zum Zitat Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, Cook JD, Kowdley KV (1998) Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 129:932–939 Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, Cook JD, Kowdley KV (1998) Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med 129:932–939
26.
Zurück zum Zitat Zhang Y, Li B, Chen C, Gao Z (2009) Hepatic distribution of iron, copper, zinc and cadmium-containing proteins in normal and iron overload mice. Biometals 22:251–259CrossRef Zhang Y, Li B, Chen C, Gao Z (2009) Hepatic distribution of iron, copper, zinc and cadmium-containing proteins in normal and iron overload mice. Biometals 22:251–259CrossRef
27.
Zurück zum Zitat Vayenas DV, Repanti M, Vassilopoulos A, Papanastasiou DA (1998) Influence of iron overload on manganese, zinc, and copper concentration in rat tissues in vivo: study of liver, spleen, and brain. Int J Clin Lab Res 28:183–186CrossRef Vayenas DV, Repanti M, Vassilopoulos A, Papanastasiou DA (1998) Influence of iron overload on manganese, zinc, and copper concentration in rat tissues in vivo: study of liver, spleen, and brain. Int J Clin Lab Res 28:183–186CrossRef
28.
Zurück zum Zitat Bartfay WJ, Bartfay E (2002) Decreasing effects of iron toxicosis on selenium and glutathione peroxidase activity. West J Nurs Res 24:119–131CrossRef Bartfay WJ, Bartfay E (2002) Decreasing effects of iron toxicosis on selenium and glutathione peroxidase activity. West J Nurs Res 24:119–131CrossRef
29.
Zurück zum Zitat Moriarty PM, Picciano MF, Beard JL, Reddy CC (1995) Classical selenium-dependent glutathione peroxidase expression is decreased secondary to iron deficiency in rats. J Nutr 125:293–301 Moriarty PM, Picciano MF, Beard JL, Reddy CC (1995) Classical selenium-dependent glutathione peroxidase expression is decreased secondary to iron deficiency in rats. J Nutr 125:293–301
30.
Zurück zum Zitat Chareonpong-Kawamoto N, Yasumoto K (1995) Selenium deficiency as a cause of overload of iron and unbalanced distribution of other minerals. Biosci Biotechnol Biochem 59:302–306CrossRef Chareonpong-Kawamoto N, Yasumoto K (1995) Selenium deficiency as a cause of overload of iron and unbalanced distribution of other minerals. Biosci Biotechnol Biochem 59:302–306CrossRef
31.
Zurück zum Zitat Giray B, Riondel J, Arnaud J, Ducros V, Favier A, Hincal F (2003) Iodine and/or selenium deficiency alters tissue distribution pattern of other trace elements in rats. Biol Trace Elem Res 95:247–258CrossRef Giray B, Riondel J, Arnaud J, Ducros V, Favier A, Hincal F (2003) Iodine and/or selenium deficiency alters tissue distribution pattern of other trace elements in rats. Biol Trace Elem Res 95:247–258CrossRef
32.
Zurück zum Zitat Dawson EB, Albers JH, McGanity WJ (2000) The apparent effect of iron supplementation on serum selenium levels in teenage pregnancy. Biol Trace Elem Res 77:209–217CrossRef Dawson EB, Albers JH, McGanity WJ (2000) The apparent effect of iron supplementation on serum selenium levels in teenage pregnancy. Biol Trace Elem Res 77:209–217CrossRef
33.
Zurück zum Zitat Viita LM, Mutanen ML, Mykkänen HM (1989) Selenium–iron interaction in young women with low selenium status. J Hum Nutr Diet 2:39–42CrossRef Viita LM, Mutanen ML, Mykkänen HM (1989) Selenium–iron interaction in young women with low selenium status. J Hum Nutr Diet 2:39–42CrossRef
34.
Zurück zum Zitat Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G (2000) The anti cancer council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health 24:576–583CrossRef Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G (2000) The anti cancer council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health 24:576–583CrossRef
35.
Zurück zum Zitat FSANZ (2006) NUTTAB 2006: Australian food composition tables. Australian Government Publishing Service, Canberra FSANZ (2006) NUTTAB 2006: Australian food composition tables. Australian Government Publishing Service, Canberra
36.
Zurück zum Zitat Abiaka C, Al-Awadi F, Olusi S (2000) Effect of prolonged storage on the activities of superoxide dismutase, glutathione reductase and glutathione peroxidase. Clin Chem 46:566–567 Abiaka C, Al-Awadi F, Olusi S (2000) Effect of prolonged storage on the activities of superoxide dismutase, glutathione reductase and glutathione peroxidase. Clin Chem 46:566–567
37.
Zurück zum Zitat Saeed K, Thomassen Y, Langmyhr FJ (1979) Direct electrothermal atomic absorption spectrometric determination of selenium in serum. Anal Chim Acta 110:285–289CrossRef Saeed K, Thomassen Y, Langmyhr FJ (1979) Direct electrothermal atomic absorption spectrometric determination of selenium in serum. Anal Chim Acta 110:285–289CrossRef
38.
Zurück zum Zitat Meret S, Henkin RI (1971) Simultaneous direct estimation by atomic absorption spectrophotometry of copper and zinc in serum, urine, and cerebrospinal fluid. Clin Chem 17:369–373 Meret S, Henkin RI (1971) Simultaneous direct estimation by atomic absorption spectrophotometry of copper and zinc in serum, urine, and cerebrospinal fluid. Clin Chem 17:369–373
39.
Zurück zum Zitat Baty D, Terron Kwiatkowski A, Mechan D, Harris A, Pippard MJ, Goudie D (1998) Development of a multiplex ARMS test for mutations in the HFE gene associated with hereditary haemochromatosis. J Clin Pathol 51:73–74CrossRef Baty D, Terron Kwiatkowski A, Mechan D, Harris A, Pippard MJ, Goudie D (1998) Development of a multiplex ARMS test for mutations in the HFE gene associated with hereditary haemochromatosis. J Clin Pathol 51:73–74CrossRef
40.
Zurück zum Zitat Aickin M, Gensler H (1996) Adjusting for multiple testing when reporting research results: the Bonferroni versus Holm methods. Am J Public Health 86:726–728CrossRef Aickin M, Gensler H (1996) Adjusting for multiple testing when reporting research results: the Bonferroni versus Holm methods. Am J Public Health 86:726–728CrossRef
41.
Zurück zum Zitat Xia Y, Hill KE, Byrne DW, Xu J, Burk RF (2005) Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 81:829–834 Xia Y, Hill KE, Byrne DW, Xu J, Burk RF (2005) Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 81:829–834
42.
Zurück zum Zitat Thomson CD (2004) Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 58:391–402CrossRef Thomson CD (2004) Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 58:391–402CrossRef
43.
Zurück zum Zitat Samaras K, Kelly PJ, Campbell LV (1999) Dietary underreporting is prevalent in middle-aged British women and is not related to adiposity (percentage body fat). Int J Obes Relat Metab Disord 23:881–888CrossRef Samaras K, Kelly PJ, Campbell LV (1999) Dietary underreporting is prevalent in middle-aged British women and is not related to adiposity (percentage body fat). Int J Obes Relat Metab Disord 23:881–888CrossRef
44.
Zurück zum Zitat Kristal AR, Peters U, Potter JD (2005) Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev 14:2826–2828CrossRef Kristal AR, Peters U, Potter JD (2005) Is it time to abandon the food frequency questionnaire? Cancer Epidemiol Biomarkers Prev 14:2826–2828CrossRef
45.
Zurück zum Zitat Franchini M (2006) Hereditary iron overload: update on pathophysiology, diagnosis, and treatment. Am J Hematol 81:202–209CrossRef Franchini M (2006) Hereditary iron overload: update on pathophysiology, diagnosis, and treatment. Am J Hematol 81:202–209CrossRef
46.
Zurück zum Zitat Papanikolaou G, Pantopoulos K (2005) Iron metabolism and toxicity. Toxicol Appl Pharmacol 202:199–211CrossRef Papanikolaou G, Pantopoulos K (2005) Iron metabolism and toxicity. Toxicol Appl Pharmacol 202:199–211CrossRef
47.
Zurück zum Zitat Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI (2003) Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102:2670–2677CrossRef Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI (2003) Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102:2670–2677CrossRef
48.
Zurück zum Zitat Pantopoulos K, Weiss G, Hentze MW (1996) Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways. Mol Cell Biol 16:3781–3788 Pantopoulos K, Weiss G, Hentze MW (1996) Nitric oxide and oxidative stress (H2O2) control mammalian iron metabolism by different pathways. Mol Cell Biol 16:3781–3788
49.
Zurück zum Zitat Mueller S, Pantopoulos K, Hubner CA, Stremmel W, Hentze MW (2001) IRP1 activation by extracellular oxidative stress in the perfused rat liver. J Biol Chem 276:23192–23196CrossRef Mueller S, Pantopoulos K, Hubner CA, Stremmel W, Hentze MW (2001) IRP1 activation by extracellular oxidative stress in the perfused rat liver. J Biol Chem 276:23192–23196CrossRef
50.
Zurück zum Zitat Nahon P, Sutton A, Pessayre D, Rufat P, Charnaux N, Trinchet JC, Beaugrand M, Deugnier Y (2011) Do genetic variations in antioxidant enzymes influence the course of hereditary hemochromatosis? Antioxid Redox Signal 15(1):31–38CrossRef Nahon P, Sutton A, Pessayre D, Rufat P, Charnaux N, Trinchet JC, Beaugrand M, Deugnier Y (2011) Do genetic variations in antioxidant enzymes influence the course of hereditary hemochromatosis? Antioxid Redox Signal 15(1):31–38CrossRef
51.
Zurück zum Zitat Stickel F, Osterreicher CH, Datz C, Ferenci P, Wolfel M, Norgauer W, Kraus MR, Wrba F, Hellerbrand C, Schuppan D (2005) Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis. Arch Intern Med 165:1835–1840CrossRef Stickel F, Osterreicher CH, Datz C, Ferenci P, Wolfel M, Norgauer W, Kraus MR, Wrba F, Hellerbrand C, Schuppan D (2005) Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis. Arch Intern Med 165:1835–1840CrossRef
Metadaten
Titel
Effect of hereditary haemochromatosis genotypes and iron overload on other trace elements
verfasst von
Jeffrey M. Beckett
Madeleine J. Ball
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
European Journal of Nutrition / Ausgabe 1/2013
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-012-0319-3

Weitere Artikel der Ausgabe 1/2013

European Journal of Nutrition 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.